International
Lung Cancer SummitVirtual Live Conference
from October 13: University Hospital Geneva
all lectures now available on demand!
REGISTRATION STILL OPEN
Alfredo Addeo, MD
Alfredo Addeo, MD, is a Consultant Medical Oncologist at the University Hospital of Geneva, Switzerland. He is the author of numerous national and international peer-reviewed publications in renowned scientific journals, including first- and last-author publications in the Journal of Clinical Oncology, Annals of Oncology and Lancet Oncology. He has acted as a reviewer for several international scientific journals, including Journal of Thoracic Oncology and JAMA Oncology, and is an associate editor for Frontiers in Thoracic Oncology and guest editor for Precision Cancer Medicine. Dr. Addeo is an active ESMO member and a member of the EORTC lung group. He actively participates in ETOP (European Thoracic Oncology Platform) and SAKK (the Swiss Group for Clinical Cancer Research) and is a researcher and co-investigator of several national and international studies.
Solange Peters, MD-PhD
Solange Peters, MD-PhD, is Professor and chair of Medical Oncology as well as the Thoracic Malignancies programme in the department of oncology at the University Hospital of Lausanne, Switzerland. She has authored numerous peer-reviewed manuscripts and book chapters, and serves as deputy editor of the Journal of Thoracic Oncology, and on the editorial board of several other oncology journals. Professor Peters is active in the educational programs of the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC), notably working as the current editor of the ESMO lung cancer clinical practice guidelines. She is the Chair of ESMO Women for Oncology Committee, and she is the youngest ESMO President ever, for a mandate in 2020-2021. She was also a member of the IASLC board of directors, and acts as vice president of the Swiss Group for Clinical Cancer Research lung group. She received both her doctorate in medicine and PhD from the University Hospital of Lausanne, Switzerland. After completing her clinical education in medical oncology and molecular biology in Switzerland and Italy, Professor Peters has specialized in thoracic tumors, lung cancer, and pleural tumors.
Giuseppe Banna
Candiolo Cancer Institute Turin, Italy
Hossein Borghaei
Fox Chase Cancer Center Philadelphia, USA
Antonio Calles
Hospital General Univ. Gregorio Marañón, Spain
Alessandra Curioni
University Hospital Zurich, Switzerland
Stephen Finn
St. James Hospital, Trinity College Dublin, Ireland
Alex Friedlaender
Clinique Générale-Beaulieu Univ. Hosp. Geneva, Switzerland
Christine Lovly
Vanderbilt Medical Center, Nashville, USA
Jarushka Naidoo
Beaumont Hospital Dublin, Ireland
Vanita Noronha
Tata Memorial Hospital, Mumbai, India
Ronwyn van Eeden
Medical Oncology Centre Rosebank, South Africa
Following the great success of the virtual International Lung Cancer Summit (ILCS), we look forward to welcoming you to the 3rd edition of this interactive hybrid meeting. Similar to recent years, the ILCS will showcase latest discoveries and advances performed towards the treatment of lung cancer. The conference will leverage digital channels to provide with an exceptional outreach and opportunity for delegates from Medical Offices, Universities and Institutes to interact with world-class Medical Oncologists and Industry Professionals working in the field of lung cancer treatment and research.
The ILCS constitutes an ideal platform to share knowledge and seamless treatment procedures with our local and international speakers from the USA, Spain, Ireland, Italy, South Africa, India and Switzerland.
This meeting is accredited and CME-certified by the Swiss Society of Medical Oncology with 5 credit points. Join us and get your certificate of attendance in the virtual meeting room.
SSMO • SSOM • SGMO
Wednesday, 13 October 2021 – All Talks Now Available On Demand!
Indicated Time Zone: Central European Summer Time (CEST)
10.00
Welcome by Chairs
Solange Peters & Alfredo Addeo (Switzerland)
10.05
Latest treatment updates for frontline non-oncogene addicted NSCLC
Hossein Borghaei (USA)
10.30
How do we tailor treatments for later lines of therapy in the IO era
Giuseppe Banna (United Kingdom)
11.00
Integrating immunotherapy into localized NSCLC
Antonio Calles (Spain)
11.20
Open discussion & coffee break
11.45
Current standard of care and challenges in Small Cell Lung Cancer
Alessandra Curioni (Switzerland)
12.10
The art of balance: approaching immune-related adverse events in thoracic oncology
Jarushka Naidoo (Ireland)
13.00
13.45
State of the art in biopsy testing: the paths we set for lung cancer treatment
Stephen Finn (Ireland)
14.10
The latest on targeting EGFR+ Non-Small Cell Lung Cancer
Vanita Noronha (India)
14.40
ALK+ and ROS1: which TKI is suitable for which patient?
Alex Friedlaender (Switzerland)
15.00
Open discussion & coffee break
15.20
KRAS and HER2: Expanding the horizons for the treatment of lung cancer
Christine Lovly (USA)
15.45
RET, MET, NTRK… a new era for targeted therapies in all mutations?
Ronwyn van Eeden (South Africa)
16.10
Wrap up & Final Questions
Solange Peters & Alfredo Addeo (Switzerland)
The International Lung Cancer Summit 2021 was made possible with the kind support by our partners with no influence on the content:
